Autoimmunity
Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis
Expression and Regulation of Fas and Fas Ligand on Thyrocytes and Infiltrating Cells During Induction and Resolution of Granulomatous Experimental Autoimmune Thyroiditis
Molecular Evolution of Catalytic Antibodies in Autoimmune Mice
Immune regulation
L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes
Peroxisome Proliferator-Activated Receptor- Agonist 15-Deoxy-12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis
The Role of IL-12 in the Induction of Intravenous Tolerance in Experimental Autoimmune Encephalomyelitis
Inflammation
Inhibition of Nitric Oxide Synthase Initiates Relapsing Remitting Experimental Autoimmune Encephalomyelitis in Rats, Yet Nitric Oxide Appears to be Essential for Clinical Expression of Disease
Lupus
A Peptide DNA Surrogate Accelerates Autoimmune Manifestations and Nephritis in Lupus-Prone Mice
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
Organ specific autoimmune diseases
A Role for IL-15 in Driving the Onset of Spontaneous Autoimmune Thyroiditis?
Genetic Analysis of Autoimmune Sialadenitis in Nonobese Diabetic Mice: A Major Susceptibility Region on Chromosome 1
De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis
A Unique Combination of Inflammatory Cytokines Enhances Apoptosis of Thyroid Follicular Cells and Transforms Nondestructive to Destructive Thyroiditis in Experimental Autoimmune Thyroiditis
Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice
Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis
Role of TGF in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice
Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes
Dual Role of the IL-12/IFN- Axis in the Development of Autoimmune Myocarditis: Induction by IL-12 and Protection by IFN-
Dominant Autoimmune Epitopes Recognized by Pemphigus Antibodies Map to the N-Terminal Adhesive Region of Desmogleins
Rheumatoid arthritis
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Concomitant Leflunomide Therapy in Patients with Active Rheumatoid Arthritis despite Stable Doses of Methotrexate: A Randomized, Double-Blind, Placebo-Controlled Trial
Rheumatoid Arthritis—A Molecular Understanding
Are Long-Term Very Low Doses of Prednisone for Patients with Rheumatoid Arthritis as Helpful as High Doses Are Harmful?
Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Rheumatology
Progress in the treatment of rheumatic disease
Summary
Tumor necrosis factor-ALPHA , its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloid
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis of the hands, after application of a structured management protocol
Efficacy and safety of the fully human anti-tumour necrosis factor monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor blockers can make sense
Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis
Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus and Accelerated Atherosclerosis
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
